Morsy KH, Zaghloul A, Mahmoud M. Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?. Turkish Journal of Gastroenterology [Internet]. 2016 Jan. 1 [cited 2026 Jan. 1];27(1):55-61. Available from: https://www.turkjgastroenterol.org/index.php/tjg/article/view/2836